Natural killer cell therapies

Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations

Life Sciences, Immunology, Oncology +12

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity

Robert L. Shields, Jadine Lai, Rodney G. Keck et al. · Journal of Biological Chemistry · 2002 · 1.8K citations · Full text

Life Sciences, Biochemistry, Immunology +16

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

Jan P. Böttcher, Eduardo Bonavita, Probir Chakravarty et al. · Cell · 2018 · 1.8K citations · Full text

Medicine, Immunology, Oncology +17

„Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

Rolf Kiessling, Eva Klein, Hans Wigzell · European Journal of Immunology · 1975 · 1.8K citations

Life Sciences, Cell Biology, Immunology +9